88IV - PR Newswire Asia's news - Health Care/Hospital


Alebund Pharmaceuticals Announces Completion of Patient Enrollment in Global Phase III Pivotal Multi-Regional Clinical Trial of AP301 for Hyperphosphatemia SHANGHAI , May 6, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative ... 2026-05-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation CAMBRIDGE, Mass. , May 6, 2026 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, announ ced the launch of its ... 2026-05-06T Health Care/Hospital Medical/Pharmaceuticals
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026 GUANGZHOU, China , May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced ... 2026-05-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026) HONG KONG , May 6, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the 33rd European Congress on Obesity ... 2026-05-06T Health Care/Hospital Medical/Pharmaceuticals
ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds MAASTRICHT, Netherlands , May 6, 2026 /PRNewswire/ -- A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 shows that after decades of decline, stroke incidence ... 2026-05-06T Health Care/Hospital
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1 PEDMARQSI ® is now TGA registered in Australia for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid ... 2026-05-06T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1 PEDMARQSI ® is now TGA registered in Australia for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid ... 2026-05-06T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
CAI Launches Next Chapter with Investment from JLL Partners INDIANAPOLIS , May 5, 2026 /PRNewswire/ -- CAI, a professional services firm dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments, today announced ... 2026-05-06T Banking/Financial Service Computer/Electronics Health Care/Hospital
AI Model Analyses Body Composition to Predict Health Risks OAK BROOK, Ill. , May 5, 2026 /PRNewswire/ -- Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle ... 2026-05-05T Health Care/Hospital Medical/Pharmaceuticals
Hidden Muscle Fat Poses Danger to Heart, Metabolism OAK BROOK, Ill. , May 5, 2026 /PRNewswire/ -- Using a deep learning model to analyze the composition of large muscles on MRI, German researchers found that the proportions of intermuscular fat and lean ... 2026-05-05T Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital